Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
The United States also just canceled nearly half a billion dollars of federal funding for mRNA vaccine research targeting respiratory infections.
Simplified Text
United States canceled nearly half a billion dollars of funding for mRNA vaccine research
Confidence Score
0.900
Claim Maker
The author
Context Type
Opinion Piece
Context Details
{
    "country": "United States",
    "funding": "half a billion dollars"
}
UUID
9fdaec3f-1ba1-45f5-9198-6621c7fbcaff
Vector Index
✗ No vector
Created
September 11, 2025 at 9:29 PM (2 days ago)
Last Updated
September 11, 2025 at 9:29 PM (2 days ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.nytimes.com/2025/08/17/opinion/china-biotech.html?campaign_id=9&emc=edit_nn_20250817&instance_id=160714&nl=the-morning&regi_id=122976029&segment_id=204065&user_id=b25c5730c89e0c73f75709d8f1254337
51 claims 🔥
2 days ago
https://www.nytimes.com/2025/08/17/opinion/china-biotech.html?campaign_id=9&emc=edit_nn_20250817&instance_id=160714&nl=the-morning&regi_id=122976029&segment_id=204065&user_id=b25c5730c89e0c73f75709d8f1254337

China's biotech sector is rapidly expanding, offering cheaper and faster drug manufacturing. This challenges US dominance, sparking debate on competition and collaboration.

Biotechnology
China
United States
Pharmaceuticals
Global Competition
Economic Policy
Healthcare

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP